Although RhoA is mutated less frequently than Ras genes in cancer cells, it has been shown to be altered in certain malignancies, including angioimmunoblastic T-cell lymphoma (AITL) and adult T-cell leukemia/lymphoma (ATL), highlighting its context-dependent oncogenic potential [12,13]. This evidence concerns the gene RHOA and cancer.